Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05462158 · ClinicalTrials.gov registry record · NA
Message Testing for CKD
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 8,637
- Enrollment target
NCT05462158: Completed NA study, sponsored by University of Pennsylvania.
NCT05462158 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 8,637 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (516% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05462158, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,637 participants
- Enrollment target
Study Summary
Members of CVS/Aetna will receive one of two text messages or receive no text message at all. In the available for members condition, participants will receive a text message that says, "Two common kidney tests have been made available for members. By taking them, you could stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them." In the Checked Health condition, the message will say, "Have you checked your kidney health recently? By taking two common kidney tests, members can stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them." There will also be a group of members that do not receive a text message at all.
Primary Outcome
The investigators will examine the proportion of appointments participants make between conditions
Interventions
- BEHAVIORAL Impact of Nudges on CKD Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,637 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
What the finished NCT05462158 record still lists
NCT05462158 is an interventional study that assigns participants to a tested intervention. Its 8,637 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (516% higher).
The record links to 0 conditions, and to 1 intervention - of which Impact of Nudges on CKD Testing is the first listed.
NCT05462158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05462158 about?
NCT05462158 is a clinical study titled "Message Testing for CKD". Members of CVS/Aetna will receive one of two text messages or receive no text message at all. In the available for members condition, participants will receive a text message that says, "Two common kidney tests have been made available for members. By taking them, you could stay ahead of any problem...
What is the current status of trial NCT05462158?
This trial is currently completed. It is a NA study. The enrollment target is 8,637 participants. The study started on 2022-03-15. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05462158?
The interventions under investigation include: Impact of Nudges on CKD Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05462158?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05462158's enrollment target sits among peer trials
8,637 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI